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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S368Conclusions: We demonstrated in the present study that the lower
serum levels of PIICP, that indicate the reduction of cartilage synthesis,
were associated with the lower JSW, that is an one of the typical signs of
OA. We speculate that the joint space narrowing could occur when the
cartilage repair system is burned out according to the lower cartilage
synthesis potential. In conclusion, the lower cartilage synthesis was
associated with the radiographic joint space narrowing of the knee joint
in men in early forties.
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MANGIFERIN STIMULATES CHONDROGENIC DIFFERENTIATION OF
MESENCHYMAL STEM CELLS FROM SUBCHONDRAL BONE AND
TARGETS MULTIPLE ASPECTS OF SMADS AND SOX9 PATHWAYS
J. Huh, P. Koh, B-K. Seo, Y-H. Baek, D-Y. Choi, J-D. Lee, D-S. Park. Kyung
Hee Univ., Seoul, REPUBLIC OF KOREA
Purpose: To assess the effect that mangiferin(1), a standard component
of WIN-34B, has on chondrogenic differentiation of mesenchymal stem
cells(MSCs) from rabbit subchondral bone.
Methods: Histological analysis was performed by alcian blue, oil red O,
and alizarin red staining to evaluate if progenitor cells from rabbit
subchondral bone have chondrogenic, adipogenic, and osteogenic dif-
ferentiation capacity. Changes in levels of chondrogenic markers type II
a1 collagen(col2a1), cartilage protein, SOX9, and aggrecan after man-
giferin treatment in IL-1b-stimulated MSCs were observed. Sulfated
glycosaminoglycan(sGAG), type II collagen, chondrogenic markers
col2a1, cartilage link protein, SOX9, aggrecan, proinﬂammatory cyto-
kines, matrix metallo proteinases(MMPs), and growth factors bone
morphogenic protein-2(BMP-2), BMP-4, basic ﬁbroblast growth fac-
tor(bFGF), and transforming growth factor-b(TGF-b) which are related
to chondrogenesis were also observed for changes in the same setting.
The mRNA expression was assessed by real time polymerase chain
reaction(RT-PCR), and protein levels were determined by ELISA assay.
Changes in chondrogenesis-related pathways Smad and SOX9 were
observed by Western blotting.
Results: sGAG and type II collagen increased after IL-1b-stimulated
MSCs, and decreased after mangiferin administration. Chondrogenic
markers col2a1, cartilage link protein, SOX9, and aggrecan were
decreased in IL-1b-stimulated MSCs, but increased after mangiferin
treatment. Proinﬂammatory cytokines(IL-1b, TNF-a) and MMP-1, MMP-
3 which increased after IL-1b stimulation of MSCs decreased after
mangiferin treatment. Chondrogenesis-related growth factors BMP-2,
BMP-4, bFGF, TGF-b were decreased in IL-1b-stimulated MSCs, but
increased after mangiferin treatment. Western blotting of IL-1b-
stimulated MSCs revealed that IL-1b disrupted chondrogenic differ-
entiation by down-regulation of phosphorylation of Smad2, 3, 1/5/8 and
SOX 9, and mangiferin up-regulated phosphorylation of Smad2,3 1/5/8
and SOX 9 and thus restored chondrogenic differentiation.
Conclusions: Mangiferin has chondroprotective and chondrogenic
differentiation promoting effects on MSCs from subchondral bone, and
does so by acting on the Smad and SOX9 pathways.
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IDENTIFYING STRUCTURAL CUES INVOLVED WITH OSTEOARTHRITIS
DISEASE IN HUMAN HUMERAL HEADS
D.J. Pawson y, M. Glanzmann z, H. Bangar y, K. Atal y, R. M€uller y,
K.S. Stok y. y ETH Zurich, Zurich, Switzerland; z Schulthess Clinic, Zurich,
Switzerland
Purpose: The concomitant structural changes to bone and cartilage in
osteoarthritis (OA) are poorly understood. It is known that both tissues
are affected, speciﬁcally degradation of cartilage alongside change to
subchondral trabecular bone structure. However, a one-to-one assess-
ment of the two tissues in relation to each other is not available. This
insight would allow categorization of disease state, as well as targeted
drug treatment for structure-modifying effects or plans of care for
physical therapy. The aim of this study is evaluate humeral heads from
end stage OA patients to correlate spatially relevant structural change
between the cartilage and bone tissues.
Methods: Humeral head samples were harvested from 9 female
patients undergoing joint replacement for end stage OA. Consent from
the patients and approval of the local ethics committee was received.
Average patient age at resection was 72 þ/- 15 years, and body mass
index of 27 þ/- 5 kg/m2. Patient history was recorded includingsecondary conditions (e.g. osteoporosis or rheumatoid arthritis) and
ongoing osteoporosis or glucocorticoid treatment, i.e. treatments with
potential structural effects.
Following surgery, the samples were scanned using micro-computed
tomography, microCT (mCT 80, Scanco Medical, Br€uttisellen, CH) at an
isotropic voxel size of 30 mm, followed by magnetic resonance imaging,
MRI (Achieva, 3.0 Tesla, Philipps, Andover, MA, USA). The samples were
immersed in Fombolin oil to enhance cartilage contrast, and scanned at
150 mm in-plane (300 mm out-of-plane) resolution using a T1 enhanced
Gradient Echo Sequence, with water selective excitation. The cartilage
was extracted from the MRI images, and then registered with the
microCT scan for further processing. Five anatomical regions of interest
were deﬁned for each sample (i.e. anterior, lateral, medial, posterior and
a central core).
Quantitative bone and cartilage morphometric analysis was then per-
formed for standard measures such as bone volume density (BV/TV),
trabecular thickness (Tb.Th), trabecular spacing (Tb.Sp), and cartilage
thickness (Cg.Th). Also the denuded surface was calculated as the per-
centage of bone surface not covered by cartilage, (%DS). Morphometric
parameters of interest were then plotted. Gross visual examination of
the data was compared with morphometry and patient history to
identify patterns of interest that could explain correlated data.
Results: Gross visual examination indicated that the samples fell into
two groups - effectively those with an osteoporosis-like structure (n ¼
2), often displaying large regions of very low to no trabeculae, ﬁgure 1a,
and those with overt sclerosis of the subchondral bone (n ¼ 6), often in
the presence of large holes (visualised as bone marrow oedema on the
MRI scans) and osteophytes, ﬁgure 1b. One sample ﬁt into neither
categorization, appearing structurally “healthy”. This sample was
omitted from the subsequent analysis. No correlation was observed
between the categorisation of a sample and the patient history.
Figure 1. (a) Osteoporosis-like sample with intact cartilage and complete
loss of trabecular structure (indicated by arrow), (b) Sclerotic sample with
loss of cartilage covering the bone, osteophyte growth (right arrow), and
large bone marrow oedema holes (left arrows). Colour indicates cartilage
thickness, where blue is thinnest and red is thickest.
Morphometric analysis indicated that the two samples with an osteo-
porosis-like structure showed no relation to cartilage measures (%DS or
Cg.Th). However for samples with sclerotic bone change, there were
signiﬁcant correlations between the bone and cartilagemorphometry, p
< 0.01. Speciﬁcally, in regions of thin cartilage the trabecular thickness
was thicker and vice versa (see ﬁgure 2a), and for regions with a large %
DS, the BV/TV was also greater (see ﬁgure 2b). Additionally, the dense
bone and loss of cartilage appeared to predominantly affect the anterior
region of the humeral heads.
